CDLX Form 4: 14,350 RSUs vested; 7,799 shares sold for taxes
Rhea-AI Filing Summary
Amit Gupta, Cardlytics, Inc. (CDLX) Chief Executive Officer and director, reported vesting and sales tied to restricted stock units. On 10/01/2025 14,350 RSUs vested (each convertible into one share) and were recorded as an acquisition event. To cover tax withholding for that vesting, 7,799 shares were sold on 10/02/2025 at a weighted average price of $2.271, with reported sale prices ranging from $2.21 to $2.36. After these transactions, the Reporting Person beneficially owned 498,310 shares directly and had 28,699 RSU-based shares remaining that will convert to common stock if vesting conditions are met. The original RSU grant totaled 114,796 shares and vests in eight equal installments through 04/01/2026.
Positive
- RSU vesting of 14,350 shares indicates continued executive compensation alignment
- Disclosure clearly states sale was solely to satisfy tax withholding, not for other liquidity purposes
Negative
- Share count reduced by 7,799 sold shares, lowering direct beneficial ownership to 498,310
- Weighted average sale price of $2.271 reflects low per-share proceeds for the sale
Insights
Routine RSU vesting with tax-sale of shares; ownership modestly reduced.
The filing shows a standard vesting event of 14,350 RSUs on 10/01/2025 converting to the same number of shares.
The Reporting Person sold 7,799 shares on 10/02/2025 solely to satisfy tax withholding, at a weighted average price of $2.271, with prices between $2.21 and $2.36.
This leaves 498,310 directly owned shares and 28,699 RSU-derived shares unissued but attributable; the remaining RSU tranche schedule runs through 04/01/2026.
FAQ
What did Amit Gupta report on Form 4 for CDLX?
How many shares does Amit Gupta beneficially own after these transactions?
At what price were the withholding shares sold?
What is the size and schedule of the RSU award mentioned?
Were the shares sold for reasons other than tax withholding?